This Website is for Irish Healthcare Professionals Only

This Website is for Irish Healthcare Professionals Only

Product materials

Medical device vigilance

To report an adverse event or any other incidents regarding Lacrifill®, please write to:
lacrifill-vigilance@nordicpharma.com.
Reporting forms and information can also be found at https://www.hpra.ie

REFERENCES

  1. Packer M, Lindstrom R, Thompson V, Parekh JG, Gupta P, Nijm LM, Donnenfeld E. Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye. J Cataract Refract Surg. 2024 Oct 1;50(10):1051-1057.
  2. Lacrifill® Instructions for use.
Lacrifill | Ireland
Nordic Pharma Logo
Lacrifill | Ireland
Nordic Pharma Logo

IE-LAC-2600017 | March 2026

© 2026 Nordic Pharma, All rights reserved.
Lacrifill® is a registered trademark of Nordic Pharma.

Go to Top